CRF Health Wins Technology Company of the Year
News May 18, 2016
CRF Health, the leading global provider of eCOA solutions for the life sciences industry, today announced that it has won the Technology Company of the Year award at the 2016 Philadelphia Alliance for Capital and Technology (PACT) Enterprise awards. The honor recognizes CRF Health’s innovative technology solutions aimed at Life Science companies, strategic growth, as well as its go to market strategies which have propelled the company to become the global leader in electronic Clinical Outcomes Assessments for clinical trials.
The win comes the same week that CRF Health launches the latest addition to its technology portfolio, TrialConsent™, an industry-first electronic informed consent solution fully integrated within an eCOA platform.
The company’s CEO, Rachael Wyllie, commented, “We are delighted to have been named as the Technology Company of the Year, particularly in the same week that we launch our latest solution to the market. Our team focus on advancing innovation in our field and growing our suite of solutions focused on participants in the clinical trial process has resulted in this recognition. This, combined with the pharmaceutical industry’s growing recognition of the positive impact eCOA has on patient engagement and study success, keeps us forward focused and ensures we are the first choice eCOA partner for biopharmaceutical companies large and small.”
The PACT Enterprise Awards are presented annually and are one of the Greater Philadelphia region’s most prestigious business honors for the achievements of technology and life science companies, leaders and entrepreneurs. The Technology Company category recognizes outstanding leadership and product innovation, in addition to an organization’s financial accomplishments and contribution to its community and industry.
CRF Health’s eCOA solutions streamline complex processes and deliver reliable results for superior clinical trial outcomes. By improving patient engagement with intuitive design, supporting study teams with tailored scientific insights, and securing high quality data with precision, CRF Health is helping to ease the path to approval for many new medicines. Founded in 2000, the company is one of Philadelphia’s fastest growing technology companies with more than 550 staff in five locations across two continents.
For more information on CRF Health's eCOA solutions, please visit www.crfhealth.com.
About CRF Health
CRF Health is the leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. With experience in more than 800 trials, over 100 languages and across 74 countries, CRF Health’s TrialMax® eCOA solutions consistently demonstrate the industry’s highest data accuracy, patient and site compliance, and patient retention.
CRF Health’s TrialMax eCOA solutions improve trial engagement by fitting into the lives of patients and seamlessly integrating into sites to maximize protocol compliance. Their eCOA solutions include PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes) and ClinROs (Clinician or Rater Reported Outcomes).
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.